氢化可的松片的规格

Specifications: Hydrocortisone tablets are oral medications in tablet form, available in two specifications: 10mg and 20mg. Suitable for replacement therapy of adrenal insufficiency and treatment of congenital adrenal hyperplasia. The recommended dose for adult patients is 20-30 mg daily, 2/3 taken in the morning and 1/3 after lunch. When there is stress, the dosage should be increased appropriately, up to 80mg per day, taken in divided doses.

The dosage of hydrocortisone for pediatric patients is 20 to 25/m2 per day based on body surface area, divided into 3 times and taken once every hour. It is prohibited for those who are allergic to this product and other steroid hormones.

Hydrocortisone tablets are easily absorbed from the digestive tract. The blood concentration reaches its peak in about 1 hour, T1/2 is about 100 minutes, and the biological half-validity is about 8 to 12 hours. More than 90% of it is bound to plasma proteins in the blood, of which 80% is bound to corticosteroid transporter (CBG). Hydrocortisone tablets are mainly metabolized by the liver and converted into tetrahydrocortisone and tetrahydrocortisone. Most of the metabolites are combined into glucuronide esters, and a very small number are excreted in the urine in their original form.

Severe mental illness (past or present) and epilepsy, active peptic ulcer disease, recent gastrointestinal anastomosis surgery, fractures, trauma repair period, corneal ulcers, hyperadrenocorticism, hypertension, diabetes, pregnant women, fungal infections that cannot be controlled by antibiotics, chickenpox, measles, severe osteoporosis, etc. The above-mentioned conditions should weigh the pros and cons of using hydrocortisone before deciding whether to use it. It is necessary to pay attention to the deterioration of the condition during medication.

It is understood that the prices currently sold in Hong Kong are relatively low. If patients have purchase needs, they can consult the medical companion travel service for specific information.

Recommended related hot articles: /newsDetail/85553.html